Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
AbbVie's US Pricing Deal Reframes Growth Prospects And R&D Commitments - Simply Wall St News
TD Waterhouse Canada Inc. Has $26.55 Million Stock Position in AbbVie Inc. $ABBV - Markets Daily
Great Lakes Advisors LLC Decreases Stock Holdings in AbbVie Inc. $ABBV
AE Wealth Management LLC Acquires 18,651 Shares of AbbVie Inc. $ABBV
New York State Common Retirement Fund Sells 129,300 Shares of AbbVie Inc. $ABBV - Daily Political
AbbVie Inc. $ABBV Stock Holdings Lifted by Fidelis Capital Partners LLC - Stock Observer
Why AbbVie Stock Trounced the Market in 2025
AbbVie (NYSE:ABBV) Stock Price Down 2.2% on Analyst Downgrade
Is AbbVie (ABBV) Pricing Reflect Its DCF And Price To Sales Signals After Recent Gains
AbbVie's Irish operations in firing line as Trump targets Botox prices
AbbVie Inc. $ABBV Shares Bought by Mirae Asset Global Investments Co. Ltd.
AbbVie (NYSE:ABBV) Shares Down 2.2% on Analyst Downgrade - Daily Political
Skin Boosters Market to Surpass USD 3,263.80 Million by 2032, Shows New Analysis on Injectable Skin Rejuvenation and Anti-Aging Trends: MMR Statistics
AbbVie Inc. $ABBV Shares Bought by Federated Hermes Inc.
AbbVie Inc. $ABBV Shares Sold by Bank of New York Mellon Corp
Truist Financial Corp Acquires 124,756 Shares of AbbVie Inc. $ABBV - Stock Observer
AbbVie (ABBV) to Release Quarterly Earnings on Wednesday
Does AbbVie's Bispecific Trial Win and R&D Pledge Change The Bull Case For AbbVie (ABBV)?
AbbVie (NYSE:ABBV) Shares Up 1.4% - Still a Buy?
AbbVie Pricing Pact And Cancer Trial Data Reframe Long Term Outlook
TGA issues fake Botox warning over 'significant' health risks
Final Trades: AbbVie, SLB, Amphenol and the IYH
AbbVie (NYSE:ABBV) Price Target Cut to $230.00 by Analysts at Citigroup - Stock Observer
Berenberg Grows More Confident in AbbVie (ABBV) on Skyrizi and Rinvoq Momentum
Why Revolution Medicines Stock Plummeted by Almost 17% Today
RET Fusion Targeted Therapies Market Set for Robust Growth by 2034 Amid Precision Oncology Shift | DelveInsight
How Recent Price Target Rethinks Are Rewriting The Story For AbbVie (ABBV)
AbbVie Inc. $ABBV Shares Sold by Parthenon LLC | MarketBeat
AbbVie Inc. $ABBV Stake Cut by Lbp Am Sa | MarketBeat
AbbVie Inc. $ABBV Position Cut by Mutual of America Capital Management LLC
Lbp Am Sa Sells 49,377 Shares of AbbVie Inc. $ABBV - Stock Observer
Mutual of America Capital Management LLC Has $47.50 Million Stake in AbbVie Inc. $ABBV - Stock Observer
Vanguard Personalized Indexing Management LLC Increases Stock Position in AbbVie Inc. $ABBV - Daily Political
AbbVie Inc. $ABBV Shares Sold by Parthenon LLC - Daily Political
Recommendations for the use of CLASI as an outcome measure in cutaneous lupus erythematosus clinical trials
Sagespring Wealth Partners LLC Has $8.81 Million Holdings in AbbVie Inc. $ABBV - Daily Political
WST: 2026 Drug Delivery Focus And New Syringe Platform Will Support Earnings Power
TrueMark Investments LLC Lowers Position in AbbVie Inc. $ABBV
ABBV: Future Returns Will Hinge On Post-Humira Immunology And Deal Optionality
Mitsubishi UFJ Trust & Banking Corp Has $260.35 Million Stock Holdings in AbbVie Inc. $ABBV - Stock Observer
Resona Asset Management Co. Ltd. Lowers Holdings in AbbVie Inc. $ABBV - Stock Observer
West Pharmaceutical Sells SmartDose Rights To AbbVie And Refocuses Portfolio
Strs Ohio Increases Stake in AbbVie Inc. $ABBV - Markets Daily
3 Stocks Including Datadog That May Be Priced Below Their Estimated Value
AbbVie Inc. $ABBV Shares Purchased by Strs Ohio - Stock Observer
Assessing AbbVie (ABBV) Valuation After Positive Phase 3 Epcoritamab Lymphoma Results
2 High-Yielding Dividend Stocks That Retirees Can Rely on for Recurring Income
AbbVie Inc. $ABBV Shares Sold by Simplicity Wealth LLC
AbbVie Inc. (NYSE:ABBV) Receives Consensus Rating of "Moderate Buy" from Analysts
AbbVie Cancer Updates Highlight Epcoritamab Data And RC148 Deal For Investors
Diagnosis, risk stratification and management of smouldering multiple myeloma
AbbVie is a top dividend stock as drug pipelines drive payout hikes
208,510 Shares in AbbVie Inc. $ABBV Purchased by Rakuten Investment Management Inc.
Vest Financial LLC Has $72.41 Million Position in AbbVie Inc. $ABBV
Bailard Inc. Acquires 16,049 Shares of AbbVie Inc. $ABBV
Vest Financial LLC Has $72.41 Million Holdings in AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. $ABBV Shares Purchased by Migdal Insurance & Financial Holdings Ltd. - Daily Political
Bernstein Sticks to Their Hold Rating for AbbVie (ABBV) | Markets Insider
Inflammation and pain as interconnected targets in axial spondyloarthritis
Dividend Stocks To Follow Now - January 20th - Markets Daily
6 JPM Healthcare Conference Announcements You Don't Want to Miss - Dealbreaker
Vaughan David Investments LLC IL Has $77.91 Million Stock Position in AbbVie Inc. $ABBV
Dynasty Wealth Management LLC Takes Position in AbbVie Inc. $ABBV
Vaughan David Investments LLC IL Has $77.91 Million Stake in AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. $ABBV Shares Purchased by Arkadios Wealth Advisors
REGENXBIO Inc. (RGNX): A Bull Case Theory
Assessing AbbVie (ABBV) Valuation After Recent Share Price Pullback
Autoimmune ADC: On the Verge of an Explosion
Violich Capital Management Inc. Grows Position in AbbVie Inc. $ABBV
Axecap Investments LLC Sells 25,567 Shares of AbbVie Inc. $ABBV
Allstate Corp Has $14.87 Million Holdings in AbbVie Inc. $ABBV
FY2025 Earnings Forecast for AbbVie Issued By Zacks Research
Best Medical Stocks To Research - January 18th - Markets Daily
Rep. Julie Johnson Sells AbbVie Inc. (NYSE:ABBV) Stock - Daily Political
Amalgamated Bank Raises Stock Position in AbbVie Inc. $ABBV
Sequoia Financial Advisors LLC Purchases 4,485 Shares of AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. $ABBV Shares Sold by Stegent Equity Advisors Inc. - Daily Political
AbbVie Inc. $ABBV Shares Sold by WoodTrust Financial Corp
QRG Capital Management Inc. Lowers Position in AbbVie Inc. $ABBV - Markets Daily
Leavell Investment Management Inc. Sells 3,208 Shares of AbbVie Inc. $ABBV - Markets Daily
QRG Capital Management Inc. Sells 75,094 Shares of AbbVie Inc. $ABBV - Stock Observer
Leavell Investment Management Inc. Sells 3,208 Shares of AbbVie Inc. $ABBV - Stock Observer
Stock Traders Purchase Large Volume of Call Options on AbbVie (NYSE:ABBV) - Stock Observer
AbbVie Inc. $ABBV Shares Bought by Pinnacle Financial Partners Inc - Daily Political
Genmab and AbbVie Drug for Blood Cancer Fails Late-Stage Trial, ETPharma
AbbVie (NYSE:ABBV) Stock Price Down 1.1% - Time to Sell?
Company Announcement Based on the topline results from the
Pharmaceutical Stocks To Keep An Eye On - January 16th - Markets Daily
How Investors May Respond To AbbVie (ABBV) $100 Billion U.S. Investment And Drug Pricing Pact
Zacks Research Comments on AbbVie's Q1 Earnings (NYSE:ABBV)
Rep. Julia Letlow Sells AbbVie Inc. (NYSE:ABBV) Stock - Markets Daily
Investors Purchase Large Volume of AbbVie Call Options (NYSE:ABBV)
Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panel
AbbVie (NYSE:ABBV) Shares Down 2.4% - Time to Sell?
Assessing RemeGen (SEHK:9995) Valuation After AbbVie RC148 Licensing Agreement
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
